Bone density changes during adjuvant aromatase inhibitor treatment in breast cancer patients: Single centre experience

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Adjuvant aromatase inhibitors (AI) therapy in breast cancer accelerates bone loss resulting in increased incidence of fracture. We evaluated the effect of AI on bone density changes among breast cancer patients in our cancer centre. © 2009 Springer-Verlag.

Cite

CITATION STYLE

APA

Almatari, M., Moe, M., Ali, P., & Willshaw, P. (2009). Bone density changes during adjuvant aromatase inhibitor treatment in breast cancer patients: Single centre experience. In IFMBE Proceedings (Vol. 25, p. 930). Springer Verlag. https://doi.org/10.1007/978-3-642-03879-2_259

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free